Question 1

What is YCT-529?

Accepted Answer

YCT-529 is a Other.

Question 2

How often does YCT-529 appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was YCT-529 first tracked by Ergen?

Accepted Answer

First tracked on Apr 07, 2026.

Question 4

When was YCT-529 last mentioned in news?

Accepted Answer

Last active on Apr 09, 2026.

Question 5

What is YCT-529's current news sentiment?

Accepted Answer

Aggregate sentiment score: 30 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is YCT-529 in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving YCT-529?

Accepted Answer

Cornell Male Contraception Breakthrough (Apr 07, 2026, 7 articles).

Question 8

How did the "Cornell Male Contraception Breakthrough" event impact YCT-529?

Accepted Answer

YCT-529 is a hormone-free male contraceptive pill developed by YourChoice Therapeutics that blocks a vitamin A metabolite, and has successfully completed its initial safety trial in humans.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.